Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Bridgehead imidazoles warding off cervical cancer

Bird flu outbreak in India: Is the awe from diseases not over yet?

National Institute of Immunology Research Job With Rs. 54,000 pm Salary

Bridgehead imidazoles warding off cervical cancer
  • BiotechToday
  • World

Bridgehead imidazoles warding off cervical cancer

bioxone January 8, 2021January 8, 2021

Biswadeep Sen, Amity University Kolkata

Every cancerous outline hosts various problems for us, and cervical cancer is no different. But recent studies show that we have indeed found a way to tackle these “slippery opponents” of ours and might be closer to finding a permanent solution.

The oncoproteins E6 and E7 of the Human Papillomavirus (HPV) are crucial for cervical cancers induced by viruses. Hence targeting these proteins is a must if we are to treat the disease. A green solvent-free method of synthesizing novel and bridgehead imidazoles might pave the way for the treatment of HPV. Imidazoles are certain organic aromatic compounds which form a part of many drugs such as antibiotics, sedatives and antifungal preparations. This recent study shows that two imidazoles-based compounds have produced promising HR-HPV inhibition with an efficacy rate as high as approximately 96%.

Results obtained from western blot analysis showed that both the compounds seem to tame down the regulation of oncoproteins E6 and E7, coupled with increased production of two other tumor suppressor proteins, namely p53 and pRb. Cell cycle analysis showed that one of the drugs of interest could induce programmed cell death (apoptosis) of the cancerous cells by arresting them at the G1 phase of the cell cycle. In this way, the drug efficiently controls the increase in the population of the cancerous cells. 

However, the ADME (absorption, distribution, metabolism, and elimination) profiles of the target compounds are still being studied to unlock their full potential as effective candidates for drugs against HPV.

Also read: Bird flu outbreak in India: Is the awe from diseases not over yet?

Source: Aisha Y. Hassan, Samiha A. El-Sebaey, Moshira. A. El-Deeb, Mona S. Elzoghbic; 2021; Potential Anticancer Effect of Imidazoles and Bridgehead Imidazoles Generated By HPV-Induced Cervical Carcinomas via Reactivating the P53/ pRb Pathway and inhibition of CA IX; Journal of Molecular Structure; 129865. https://doi.org/10.1016/j.molstruc.2020.129865

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antiviral Apoptosis cancer Cell cycle Cervical Cancer cytotoxicity E6/E7 oncoproteins HPV Human Papillomavirus Imidazoles P53/pRb pathway

One thought on “Bridgehead imidazoles warding off cervical cancer”

  1. Pingback: Climate Change and Animal Appearances: Renewed discussions on Gloger’s rule - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

National Institute of Immunology Research Job With Rs. 54,000 pm Salary

bioxone January 8, 2021

-Shristi Sharma, Team bioXone NII Jobs 2021 – PhD Research Associate Vacancy. Recruitment of Biotechnology/ Biophysics/ Biochemistry/ Life Sciences candidates at NII. Research Associate Post. Research Job Openings at NII. Check out the details given below: NII Vacancy Details Job Name: Research Associate No. of Posts: 01 Title of Project: “Regulation of neuronal cell cycle […]

Related Post

  • BiotechToday
  • World

Is Scar Tissue A Protective Immune Cell?

bioxone March 12, 2021March 12, 2021

Souradip Mallick, National Institute of Technology, Rourkela  Nowadays abdominal surgery is very common and many patients undergo this operation to remove internal scar tissue. This scar is the accumulation of the macrophage which is a protective immune cell. But there are many postsurgical complications. Lysis of adhesions destroys the scar tissue resulting in abdominal and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • World

New insulin treatment for Type 2 diabetes? Find out.

bioxone September 24, 2020September 24, 2020

Prama Ghosh, Amity University Kolkata Past information has shown that patients with type 2 diabetes would by and large lean toward fewer injections and more prominent adaptability than is typical of the current once-daily insulin treatment. Therefore, decreasing the number of injections might build acknowledgment of and adherence to insulin treatment among patients with type […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Are Care Home Residents more vulnerable to SARS-CoV-2?

bioxone March 8, 2021March 8, 2021

-Devyani Goswami, Amity University Kolkata One of the parts of the society which remains under huge threat for the spreading of the deadly SARS-CoV-2 is the care homes. Older people with health issues remain to be the vulnerable target of this virus. The shared living accommodations along with residents, staff and visitors in an enclosed […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy